AVI-4065 Injection

DRUG2 trials

Sponsors

Sarepta Therapeutics, Inc.

Conditions

EncephalitisHepatitis C

Phase 1

Study of AVI-4065 in Healthy Volunteers and Chronic Active HCV Patients

TerminatedNCT00229749

Sarepta Therapeutics, Inc.Hepatitis C

Start: 2005-09-30End: 2007-01-31Target: 80Updated: 2008-04-10

Pharmacokinetic Study of a Single Dose of AVI-4065 in Cerebral Spinal Fluid

CompletedNCT00381433

Sarepta Therapeutics, Inc.Encephalitis

Start: 2006-09-30End: 2009-06-30Target: 12Updated: 2009-07-08